Health

Britain reviews data on French breast implants

Britain's health minister said Saturday he has ordered an urgent review of the data used to assess the risks of breast implants made by French firm PIP, after receiving "conflicting" information.

Oncology & Cancer

Tamoxifen resistance linked to high estrogen levels in utero

An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward ...

page 10 from 40